Parkinson's syndrome and Parkinson's disease in mitochondrial disorders (Q37850755)

24 August 2017

1 reference

title

Parkinson's syndrome and Parkinson's disease in mitochondrial disorders (English)

1 reference

24 August 2017

1 reference

1 reference

parkinsonian syndrome

1 reference

Josef Finsterer

1

1 reference

PubMed ID

21384429

24 August 2017

language of work or name

English

0 references

publication date

7 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

26

1 reference

24 August 2017

5

1 reference

24 August 2017

784-791

1 reference

A neurological perspective on mitochondrial disease.

24 August 2017

1 reference

Mitochondrial disorders, cognitive impairment and dementia

21 January 2018

1 reference

Parkinson's disease associated with impaired oxidative phosphorylation

21 January 2018

1 reference

Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys.

21 January 2018

1 reference

Parkinson syndrome as a manifestation of mitochondriopathy

21 January 2018

1 reference

Noncompaction and endocarditis in suspected mitochondrial disorder

21 January 2018

1 reference

Mitochondrial diseases mimicking neurotransmitter defects.

21 January 2018

1 reference

Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects

21 January 2018

1 reference

Disorders of movement in Leigh syndrome

21 January 2018

1 reference

Early-onset familial parkinsonism due to POLG mutations.

21 January 2018

1 reference

MtDNA mutations in maternally inherited diabetes: presence of the 3397 ND1 mutation previously associated with Alzheimer's and Parkinson's disease

21 January 2018

1 reference

Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports

21 January 2018

1 reference

POLG1 polyglutamine tract variants associated with Parkinson's disease

21 January 2018

1 reference

Cerebrospinal fluid lactate and pyruvate concentrations in patients with Parkinson's disease and mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS)

21 January 2018

1 reference

Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal

21 January 2018

1 reference

Two novel point mutations of mitochondrial tRNA genes in histologically confirmed Parkinson disease.

21 January 2018

1 reference

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

21 January 2018

1 reference

Nature of mitochondrial DNA deletions in substantia nigra neurons

21 January 2018

1 reference

Cybrid models of Parkinson's disease show variable mitochondrial biogenesis and genotype-respiration relationships

21 January 2018

1 reference

Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues

21 January 2018

1 reference

Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease

21 January 2018

1 reference

Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update

21 January 2018

1 reference

Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology.

21 January 2018

1 reference

Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients

21 January 2018

1 reference

A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease

21 January 2018

1 reference

PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy

21 January 2018

1 reference

PINK1 is selectively stabilized on impaired mitochondria to activate Parkin

21 January 2018

1 reference

PINK1 mutations and differential effects on mitochondrial function.

21 January 2018

1 reference

Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration

21 January 2018

1 reference

PINK1 defect causes mitochondrial dysfunction, proteasomal deficit and alpha-synuclein aggregation in cell culture models of Parkinson's disease

21 January 2018

1 reference

Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells

21 January 2018

1 reference

PINK1-dependent recruitment of Parkin to mitochondria in mitophagy

21 January 2018

1 reference

How could Parkin-mediated ubiquitination of mitofusin promote mitophagy?

21 January 2018

1 reference

Parkinson disease-associated DJ-1 is required for the expression of the glial cell line-derived neurotrophic factor receptor RET in human neuroblastoma cells.

21 January 2018

1 reference

Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics

21 January 2018

1 reference

Parkinson's disease: from molecular pathways in disease to therapeutic approaches

21 January 2018

1 reference

Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease

21 January 2018

1 reference

Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions

21 January 2018

1 reference

Apoptotic mechanisms in mutant LRRK2-mediated cell death

21 January 2018

1 reference

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

21 January 2018

1 reference

A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease

21 January 2018

1 reference

Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in Parkinson disease

21 January 2018

1 reference

Mitochondrial proteomics as a selective tool for unraveling Parkinson's disease pathogenesis

21 January 2018

1 reference

The cybrid model of sporadic Parkinson's disease

21 January 2018

1 reference

Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopamine-treated mesencephalic neurons

21 January 2018

1 reference

Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance

21 January 2018

1 reference

Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions

21 January 2018

1 reference

Fibroblast growth factor 9 upregulates heme oxygenase-1 and gamma-glutamylcysteine synthetase expression to protect neurons from 1-methyl-4-phenylpyridinium toxicity

21 January 2018

1 reference

Progressive myoclonic epilepsy as an adult-onset manifestation of Leigh syndrome due to m.14487T>C.

21 January 2018

1 reference

Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle

21 January 2018

1 reference

Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene.

21 January 2018

1 reference

Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism

21 January 2018

1 reference

Additive effects of POLG1 and ANT1 mutations in a complex encephalomyopathy

21 January 2018

1 reference

Neurodegenerative Parkinsonism and progressive external ophthalmoplegia with a Twinkle mutation

21 January 2018

1 reference

Alpha-synuclein pathology and Parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.23651

1 reference

release_w2wlsyn6afh5flj4jxxqwc6iai

24 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w2wlsyn6afh5flj4jxxqwc6iai

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

21384429

1 reference

PubMed ID

21384429